Anika Therapeutics (ANIK) Research & Development (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Research & Development of $7.3 million for Q2 2026, up 16.28% year-over-year from $6.3 million in Q2 2025, and up 9.35% quarter-over-quarter from $6.7 million in Q1 2026.
Anika Therapeutics (ANIK) Research & Development (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Research & Development for 17 consecutive years, with $7.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Research & Development rose 16.28% year-over-year to $7.3 million; the TTM figure through Jun 2026 stood at $27.5 million (up 10.58% YoY), while the FY2025 annual figure was $25.8 million, up 0.88% from the prior year.
- Research & Development improved to $7.3 million in Q2 2026 per ANIK's latest filing, from $6.7 million in the prior quarter.
- Across five years, Research & Development topped out at $8.9 million in Q2 2023 and bottomed at -$3.3 million in Q4 2023.
- Historically, Research & Development has averaged $5.9 million across 5 years, with a median of $6.6 million in 2024.
- Annual changes were most pronounced in 2022 — Research & Development tumbled 135.2% — and 2024, when it soared 294.7%.
- Anika Therapeutics' Research & Development stood at -$2.1 million in 2022, then tumbled by 58.24% to -$3.3 million in 2023, then jumped by 294.7% to $6.5 million in 2024, then declined by 0.85% to $6.5 million in 2025, then climbed by 13.78% to $7.3 million in 2026.
- Business Quant data shows ANIK's Research & Development at $7.3 million in Q2 2026, $6.7 million in Q1 2026, and $6.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Anika Therapeutics | 281.53 Mn | 243.12 Mn | 21.24 Mn | 7.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.34 Mn |
| Mar 31, 2026 | 6.71 Mn |
| Dec 31, 2025 | 6.45 Mn |
| Sep 30, 2025 | 6.95 Mn |
| Jun 30, 2025 | 6.31 Mn |
| Mar 31, 2025 | 6.06 Mn |
| Dec 31, 2024 | 6.51 Mn |
| Sep 30, 2024 | 5.95 Mn |
| Jun 30, 2024 | 6.68 Mn |
| Mar 31, 2024 | 6.41 Mn |
| Dec 31, 2023 | -3.34 Mn |
| Sep 30, 2023 | 7.79 Mn |
| Jun 30, 2023 | 8.91 Mn |
| Mar 31, 2023 | 8.40 Mn |
| Dec 31, 2022 | -2.11 Mn |
| Sep 30, 2022 | 7.30 Mn |
| Jun 30, 2022 | 6.98 Mn |
| Mar 31, 2022 | 6.16 Mn |
| Dec 31, 2021 | 6.00 Mn |
| Sep 30, 2021 | 7.67 Mn |